⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Threonine SCHEMBL14946556 | 1.00 | — | — | |
| Threonine SCHEMBL17292859 | 1.00 | SLC7A5 (0.63) | — | |
| Threonine SCHEMBL117301 | 1.00 | — | — | |
| Threonine SCHEMBL9461237 | 1.00 | SLC7A5 (0.63) | — | |
| Threonine SCHEMBL14924406 | 1.00 | — | — | |
| Threonine SCHEMBL1480 | 1.00 | — | — | |
| Threonine SCHEMBL18050157 | 1.00 | SLC7A5 (0.63) | — | |
| Threonine SCHEMBL6038228 | 1.00 | SLC7A5 (0.63) | — | |
| Threonine SCHEMBL2702066 | 1.00 | SLC7A5 (0.63) | — | |
| D-Allothreonine SCHEMBL222076 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6430 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125442-A1 | PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST | LILLY CO ELI (US) | 2026-05-07 | — | — | US | claimed |
| US-20260098072-A1 | METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS | ENDEVICA BIO INC (US) | 2026-04-09 | — | — | US | claimed |
| US-20260061085-A1 | CYCLIC PEPTIDE AND PREPARATION METHOD THEREFOR, AND COMPLEX COMPRISING SAME AND USE THEREOF | HEXIN SUZHOU PHARMACEUTICAL TECH CO LTD (CN) | 2026-03-05 | — | — | US | claimed |
| US-20260001910-A1 | PEPTIDES AND USES THEREOF | PREVECEUTICAL MEDICAL INC (CA) | 2026-01-01 | — | — | US | claimed |
| EP-4665374-A1 | METHODS OF PREVENTING AND/OR TREATING SIDE EFFECTS ASSOCIATED WITH ANTI-CANCER AGENTS USING NON-NATURALLY OCCURRING MELANOCORTIN ANALOGS WITH ANTI-GDF-15 ANTIBODIES | Endevica Bio, Inc. (US) | 2025-12-24 | — | — | EP | claimed |
| WO-2025245279-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONISTS AND USE THEREFORE IN TREATMENT OF ADDICTION AND/OR PAIN | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| US-20250353797-A1 | ENDOPHYTES, ASSOCIATED COMPOSITIONS, AND METHODS OF USE | INDIGO AG INC (US) | 2025-11-20 | — | — | US | claimed |
| US-20250332226-A1 | COMPOSITIONS AND METHODS FOR TREATING SOLID CANCER | EXOXEMIS INC (US) | 2025-10-30 | — | — | US | claimed |
| US-12441765-B2 | Peptides and medical uses thereof | ANBITION S.R.L. (IT) | 2025-10-14 | — | — | US | claimed |
| US-20250282837-A1 | METHOD AND COMPOSITIONS FOR NEURONAL REPROGRAMMING | SUNNYBROOK RES INST (CA) | 2025-09-11 | — | — | US | claimed |
| US-4127524-A | ANALGESIC | VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY | 1978-11-28 | — | — | US | claimed |
| US-4127537-A | ANALGESIC | VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY | 1978-11-28 | — | — | US | claimed |
| US-4127536-A | ANALGESIC | VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY | 1978-11-28 | — | — | US | claimed |
| US-4127530-A | ANALGESIC | VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY | 1978-11-28 | — | — | US | claimed |
| US-4127531-A | ANALGESIC | VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY | 1978-11-28 | — | — | US | claimed |
| US-4127528-A | HEXADECAPEPTIDE, ANALGESIC | VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY | 1978-11-28 | — | — | US | claimed |
| US-4127529-A | ANALGESIC | VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY | 1978-11-28 | — | — | US | claimed |
| US-4127533-A | ANALGESIC | VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY | 1978-11-28 | — | — | US | claimed |
| US-4127541-A | ANALGESIC | VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY | 1978-11-28 | — | — | US | claimed |
| US-4127540-A | Novel derivatives of δ-endorphins, intermediates therefor, and compositions and methods employing said derivatives | VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY | 1978-11-28 | — | — | US | claimed |